Rottembourg, J B <br/><br/>
An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months.  [electronic resource] 

 -  Clinical nephrology  Mar 2011 
 - 242-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0301-0430 
<br/><br/><label>Standard No.: </label>10.5414/cn106749  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--blood<br/>Australia<br/>Biomarkers--blood<br/>Darbepoetin alfa<br/>Drug Administration Schedule<br/>Erythropoietin--administration & dosage<br/>Europe<br/>Female<br/>Hematinics--administration & dosage<br/>Hemoglobins--metabolism<br/>Hospitalization<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Peritoneal Dialysis--adverse effects<br/>Prospective Studies<br/>Renal Dialysis--adverse effects<br/>Retrospective Studies<br/>Time Factors<br/>Treatment Outcome